Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Anticancer Agent 146 (Compound 1.19) acts as a necroptosis inducer and demonstrates anti-tumor efficacy in the MDA-MB-231 mouse xenograft model [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry | |
50 mg | Inquiry | Inquiry |
Description | Anticancer Agent 146 (Compound 1.19) acts as a necroptosis inducer and demonstrates anti-tumor efficacy in the MDA-MB-231 mouse xenograft model [1]. |
In vitro | Anticancer agent 146 (compound 1.19) exhibits inhibitory concentration 50 (IC50) values across various cancer cell lines as follows: 8.54 μM (MDA-MB-231), 4.24 μM (MCF7), 4.67 μM (4T1), 8.02 μM (67NR), 3.36 μM (MIAPaCa-2), and 1.76 μM (WiDr) [1]. |
Molecular Weight | 375.25 |
Formula | C19H16Cl2N2O2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Anticancer agent 146 Apoptosis Necroptosis inhibitor inhibit